|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
BELLUS Health Exercises Option to Terminate Lease
1/14/2011 12:10:37 PM
LAVAL, QC, Jan. 14 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) ("BELLUS Health" or the "Company") announced today that it exercised its right to terminate the lease of its Laval, Quebec premises as of April 7, 2011 (the "Termination Option"), as provided in the amended lease agreement dated March 31, 2009 with A.R.E. Quebec No. 2, Inc. ("A.R.E."), the landlord of such premises (the "Amended Lease"). The exercise of the Termination Option will result in annual savings of approximately $4.5 million for the Company, representing a total of approximately $43 million in aggregate savings over the course of the original lease term. In consideration for the exercise of the Termination Option, BELLUS Health will issue 20,656,320 common shares from treasury to A.R.E. at a price of $0.29 per share (rounded to the second decimal point), for an aggregate value of $6 million. Pursuant to the terms of the Amended Lease, deferred rent in the amount of $4.2 million (including accrued interest thereon) will be payable to A.R.E. on April 7, 2011, in cash or, at the Company's option, through an issuance of common shares from treasury.
|
|
|
|
|
|
|
|
|
|
|